O03 Apremilast, an Oral Phosphodiesterase-4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 608.1-608
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 355.3-356
◽
2017 ◽
Vol 76
(6)
◽
pp. AB47
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 742.2-743
◽
2017 ◽
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 346.1-346
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 133-134
◽
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 341.1-341
Keyword(s):